HSA — authorised 16 July 2021
- Marketing authorisation holder: SANOFI
- Status: likely_approved
HSA authorised Fexinidazole on 16 July 2021
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 16 July 2021.
SANOFI holds the Singaporean marketing authorisation.